Pharmafile Logo
Pharmafocus logo
Advanced Search

ABPI launches legal action to overturn £20m price cap

July 11, 2017
Manufacturing and Production, Medical Communications, Sales and Marketing ABPI, NHS England, NICE

When NICE announced in March that it would impose a £20 million per year cap on the price of drugs, …

News
walnut

Brain tumours to be used to manufacture stem cells

July 10, 2017
Manufacturing and Production, Research and Development Censo Biotechnologies, University of Leeds

Censo Biotechnologies has announced that it will collaborate with the University of Leeds to use the latest stem cell technology …

News
brenda-fitzgerald-2

New director of CDC courts controversy from all angles

July 10, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CDC, Trump, US

It seems that an appointment in Trump’s administration cannot avoid being a topic of some controversy. That’s the case with …

Appointment
shutterstock_339308225

Revealing the missing evidence: Randomised real-life studies in basal insulin therapy

July 10, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Sanofi, diabetes, real world data

Sanofi’s Riccardo Perfetti, Head of Global Diabetes, and Jukka Westerbacka, Medical Director, Global Medical Affairs, discuss how the significance of …

Feature

Endo withdraws product as FDA secures step in opioid crisis fightback

July 10, 2017
Sales and Marketing Endo pharmaceuticals, FDA, Opana ER

The FDA took the unusual step to ask Endo Pharmaceutical to voluntarily withdraw its opioid painkiller, Opana ER, from the …

News
shutterstock_2

Problematic facility inspection puts Biocon’s biosimilar EU approvals on hold

July 10, 2017
Manufacturing and Production, Sales and Marketing Biocon, India, biosimilars

Indian firm Biocon has been hit by regulator criticism which has forced its European biosimilar programme on hold following a …

News
shire_image

Shire and Roche haemophilia spat spills into court

July 10, 2017
Sales and Marketing Roche, Shire, haemophilia

Roche released new scientific data at a conference in Berlin regarding its developmental drug in haemophilia, emicizumab, and Shire chose …

News
brexit_flag

European pharma pulls together to ensure ‘minimal disruption’ from Brexit

July 10, 2017
Research and Development, Sales and Marketing EMA, Europe, UK

As a consequence of the triggering of Article 50 and the UK’s exit from the EU, the EMA – currently …

News
sickle_cells

FDA gives go-ahead to first sickle cell treatment in 20 years

July 10, 2017
Sales and Marketing Emmaus Medical, L-glutamine, sickle cell disease

Emmaus Medical has been handed approval for the first new treatment for sickle cell disease in two decades. The active …

News
gagan_singh

AstraZeneca appoint new MD for India

July 7, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, India

AstraZeneca announced a new Managing Director for AstraZeneca Pharma India, with Gagan Singh Bedi beginning the role on 3 July. …

Appointment
messy_bed

Oral sex creating super-gonorrhoea

July 7, 2017
Research and Development antibiotic resistance, gonorrhoea

The WHO has announced that data from across 77 different countries show that the sexually-transmitted infection (STI) gonorrhoea is becoming …

News
top_ten_1

Top Ten most popular articles on Pharmafile.com this week

July 7, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing most read articles, most read news, top ten

It’s Friday, and we’ve brought together our weekly digest of the articles which proved most popular with our readers. Brexit …

News
celgene_1_02

Celgene plays catch up with $1.4 billion immunotherapy deal

July 7, 2017
Medical Communications, Sales and Marketing BeiGene, Celgene, immunotherapy, pd-1

Those commentating on Celgene’s latest deal seem to be equally divided between two camps: it is too much money, too …

News
shutterstock_168864905

Top 50 Selling Products in the World by 2022

July 6, 2017
Medical Communications

This article was originally published in Pharmafile Spring 2017.Opdivo and Revlimid to compete for the top spot in 2022, while …

News
shutterstock_138095450

New data shows pharma has not cut back on controversial payments to physicians

July 6, 2017
Medical Communications, Sales and Marketing Allergan, Biogen, Celgene, Sanofi, Valeant

Despite increasing controversy arising over the years due to the questionable relationship between physicians and pharma and the money which …

News
merck_entrance

FDA shutters MSD’s Keytruda combination trials in myeloma

July 6, 2017
Medical Communications, Research and Development MSD, immunotherapy, keytruda, pd-1

Following on from the news last month that enrolment for Keytruda being used alongside Celgene’s Imnovid and Revlimid would have …

News
ob_logo

Oxford BioMedica in $100 million manufacturing deal with Novartis

July 6, 2017
Manufacturing and Production, Sales and Marketing Novartis, Oxford BioMedica

Oxford BioMedica has announced that it has signed a contract with Novartis to supply the company with materials in a …

News
gilead-sciences

Gilead to launch injunction against Mylan and Actavis over HIV generics in Ireland

July 6, 2017
Sales and Marketing Actavis, Gilead, HIV, Mylan, Truvada

Gilead is expected to launch injunctive action against rivals Mylan and Actavis over the allegation that they are planning to …

News
tau_tangle

Atomic structure of tau revealed opening up new Alzheimer’s targets

July 6, 2017
Research and Development Alzheimer's disease, dementia, tau protein, tau tangle

It is a research breakthrough that has been touted as the biggest development in Alzheimer’s disease research for a quarter …

News
heart_money

Heart failure market to quadruple in ten years to $16 billion

July 6, 2017
Sales and Marketing GlobalData, Novartis, heart failure

New research from intelligence firm GlobalData has indicated that the market for heart failure drugs is forecast to expand by …

News
The Gateway to Local Adoption Series

Latest content

Thermo Fisher opens new distribution centre in Ireland

March 12, 2026

Altimetrik appoints Dhirendra Nath as Chief Human Resources Officer

March 12, 2026

Kindeva appoints Mike Cowhig as Chief Legal Officer

March 11, 2026

DiaMedica gets regulatory clearance from Health Canada for phase 2 preeclampsia study

March 11, 2026

Abselion establishes a US subsidiary in Massachusetts 

March 10, 2026